ProfileJobs

NanoString Technologies

Healthclinical researchgeneticshealthtechlife sciencesmedical diagnostics

NanoString Technologies provides life science tools for translational research and molecular diagnostic products. The Company's nCounter Analysis System offers a cost-effective way to easily profile the expression of hundreds of genes, miRNAs, or copy number variations, simultaneously with high sensitivity and precision. NanoString's technology enables a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The nCounter-based Prosigna Breast Cancer Prognostic Gene Signature Assay is the first in vitro diagnostic assay to be marketed through the company's diagnostics business. The system is positioned to support translational research because it provides more reproducible results than methods requiring amplification, and generates high-quality data from the difficult sample types common in clinical research, including Formalin-Fixed Paraffin-Embedded (FFPE) tissues.

Revenue(Q1, 2017)
$18.1 M
Market capitalization(2017-08-17)
$315.4 M
Company Growth (employees)
Type
Public
HQ
Seattle, US
Founded
2003
Size (employees)
407 (est)
Website
nanostring.com
NanoString Technologies was founded in 2003 and is headquartered in Seattle, US

Key People at NanoString Technologies

Brad Gray

Brad Gray

President and Chief Executive Officer
James Johnson

James Johnson

CFO
William Young

William Young

Executive Chairman of the Board
Wayne Burns

Wayne Burns

Senior Vice President, Operations & Administration

NanoString Technologies Office Locations

NanoString Technologies has offices in Seattle and Hong Kong
Seattle, US (HQ)
2000 530 Fairview Ave N

NanoString Technologies Data and Metrics

NanoString Technologies Financial Metrics

NanoString Technologies's revenue was reported to be $18.1 m in Q1, 2017
USD

Revenue (Q1, 2017)

18.1 m

Net income (Q1, 2017)

(18.9 m)

EBIT (Q1, 2017)

(17.5 m)

Market capitalization (17-Aug-2017)

315.4 m

Cash (31-Mar-2017)

5.4 m
NanoString Technologies's current market capitalization is $315.4 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

31.4 m47.6 m62.7 m86.5 m

Revenue growth, %

52%32%38%

Cost of goods sold

15 m

Gross profit

16.4 m

Gross profit Margin, %

52%

Operating expense total

44.9 m72.5 m77.8 m127.7 m

EBIT

(28.5 m)(46 m)(41.2 m)(41.2 m)

EBIT margin, %

(91%)(97%)(66%)(48%)

Interest expense

1.9 m4.1 m4 m5.7 m

Interest income

68 k272 k233 k390 k

Income tax expense

(166 k)(116 k)

Net Income

(29.3 m)(50 m)(45.6 m)(47.1 m)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

10.9 m12.3 m11.6 m13.1 m15.7 m14.7 m22.6 m23.9 m18.1 m

R&D expense

5.3 m6 m5.9 m5.8 m5.8 m7.2 m8.8 m8.7 m10.8 m

General and administrative expense

12.9 m12.5 m14.1 m12.8 m12 m14.9 m15.5 m15.6 m17.6 m

Operating expense total

18.2 m18.5 m20 m18.6 m17.8 m22.1 m24.3 m24.3 m28.4 m

EBIT

(12.1 m)(11.4 m)(13.8 m)(11.4 m)(8.4 m)(13.3 m)(9.6 m)(8.5 m)(17.5 m)

EBIT margin, %

(112%)(92%)(119%)(87%)(54%)(90%)(42%)(35%)(97%)

Interest expense

(2 m)(697 k)(984 k)(1 m)(1 m)(1.3 m)(1.3 m)(1.5 m)(1.5 m)

Interest income

75 k65 k67 k56 k58 k68 k94 k104 k147 k

Net Income

(14.1 m)(12.1 m)(14.9 m)(12.4 m)(9.5 m)(14.6 m)(10.8 m)(10.1 m)(18.9 m)
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

9.9 m17.2 m21.9 m20.6 m

Accounts Receivable

8.3 m12.4 m19.7 m22.2 m

Inventories

6.8 m5.4 m3.9 m13.8 m

Current Assets

60.7 m95.3 m82.8 m113.8 m

PP&E

3.1 m6.4 m9.4 m12.2 m

Total Assets

64.4 m102.7 m92.9 m126.4 m

Accounts Payable

3.4 m3.4 m3.2 m4.9 m

Current Liabilities

18.6 m18.8 m20.9 m36.4 m

Total Liabilities

114.1 m

Additional Paid-in Capital

158.3 m221.7 m242.7 m281.9 m

Retained Earnings

(126.8 m)(176.9 m)(222.5 m)(269.5 m)

Total Equity

31.5 m44.8 m20.2 m12.3 m

Financial Leverage

2 x2.3 x4.6 x10.3 x
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

21.2 m18.8 m14.3 m15.7 m16.6 m29.6 m19.3 m10.5 m5.4 m

Accounts Receivable

9.1 m15.3 m10.5 m13.2 m12.9 m15.5 m25.2 m21 m16.7 m

Inventories

6.4 m5.8 m7.9 m9.4 m11.7 m11.8 m12.5 m11.7 m14.5 m

Current Assets

99.1 m92.9 m79.3 m81.5 m74.6 m87.2 m98.5 m90.7 m92.4 m

PP&E

5.1 m5.7 m6.9 m7.2 m7.4 m10.8 m10.6 m10.7 m13.7 m

Total Assets

105.1 m99.5 m87.1 m89.8 m83 m98.7 m109.9 m102.3 m106.5 m

Accounts Payable

2.7 m2.2 m4.6 m2.4 m2.6 m3.5 m4 m2.1 m2.1 m

Current Liabilities

14.2 m15.4 m15.8 m15.9 m16 m23.1 m29.9 m28.9 m32.4 m

Additional Paid-in Capital

218.2 m220.2 m223.7 m238.2 m240.8 m245.7 m248.2 m251.4 m285.4 m

Retained Earnings

(152.3 m)(164.5 m)(191.8 m)(204.2 m)(213.6 m)(237.1 m)(247.9 m)(257.9 m)(288.4 m)

Total Equity

65.9 m55.7 m31.9 m34 m27.2 m8.6 m332 k(6.6 m)(3.1 m)

Financial Leverage

1.6 x1.8 x2.7 x2.6 x3.1 x11.5 x330.9 x-15.6 x-34.8 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(29.3 m)(50 m)(45.6 m)(47.1 m)

Depreciation and Amortization

1.8 m1.5 m2.4 m3 m

Accounts Receivable

(5 m)(4.1 m)(7.3 m)(2.5 m)

Inventories

(1.4 m)(1.3 m)(5.4 m)(5 m)

Accounts Payable

1.6 m21 k(166 k)869 k

Cash From Operating Activities

(31.3 m)(38.1 m)(43.4 m)(6.1 m)

Purchases of PP&E

(759 k)(1.9 m)(3.8 m)(4 m)

Cash From Investing Activities

(33 m)(24.3 m)23.8 m(30.3 m)

Long-term Borrowings

(211 k)(18.2 m)

Cash From Financing Activities

52.6 m69.6 m24.3 m35.1 m

Interest Paid

1.5 m3.5 m2.8 m4.1 m

Income Taxes Paid

69 k217 k
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(14.1 m)(12.1 m)(14.9 m)(12.4 m)(9.5 m)(14.6 m)(10.8 m)(10.1 m)(18.9 m)

Accounts Receivable

9.1 m15.3 m10.5 m13.2 m12.9 m15.5 m25.2 m21 m16.7 m

Inventories

6.4 m5.8 m7.9 m9.4 m11.7 m11.8 m12.5 m11.7 m14.5 m

Accounts Payable

2.7 m2.2 m4.6 m2.4 m2.6 m3.5 m4 m2.1 m2.1 m
USDY, 2017

Revenue/Employee

44.4 k

Financial Leverage

-34.8 x

NanoString Technologies Market Value History

Market Position of NanoString Technologies

Competitors

Prenetics
Health - Private
Ixico
Health - Public
Human Longevity
Technology - Private
Agilent Technologies
Technology - Public
Compare competitors

Traffic Overview of NanoString Technologies

NanoString Technologies Online and Social Media Presence

NanoString Technologies Company Life and Culture

You may also be interested in